Header Logo

Connection

RACHEL SCHIFF to Benzimidazoles

Back to Details
This is a "connection" page, showing publications RACHEL SCHIFF has written about Benzimidazoles.
RACHEL SCHIFF
Connection Strength
0.034
Benzimidazoles
  1. Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition. Mol Cancer Ther. 2018 05; 17(5):921-930.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.